Related references
Note: Only part of the references are listed.Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives
Syo Nakajima et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
Koichi Watashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The option of HBIG-free prophylaxis against recurrent HBV
Alyson N. Fox et al.
JOURNAL OF HEPATOLOGY (2012)
Cyclosporin A Inhibits the Influenza Virus Replication through Cyclophilin A-Dependent and -Independent Pathways
Xiaoling Liu et al.
PLOS ONE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
HBV life cycle and novel drug targets
Daniel Grimm et al.
HEPATOLOGY INTERNATIONAL (2011)
Hepatitis B virus resistance to antiviral drugs: where are we going?
Fabien Zoulim
LIVER INTERNATIONAL (2011)
New drugs hit the target
Jana Schluetter
NATURE (2011)
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
Susanne Pfefferle et al.
PLOS PATHOGENS (2011)
Molecular genetics of HBV infection
Stephen Locarnini et al.
ANTIVIRAL THERAPY (2010)
Practical cell-free protein synthesis system using purified wheat embryos
Kazuyuki Takai et al.
NATURE PROTOCOLS (2010)
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
Erik De Clercq et al.
VIRUSES-BASEL (2010)
Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein
Min Qing et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Target Cell Cyclophilins Facilitate Human Papillomavirus Type 16 Infection
Malgorzata Bienkowska-Haba et al.
PLOS PATHOGENS (2009)
Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: Recommendations for a standardized approach
Jean-Michel Pawlotsky et al.
GASTROENTEROLOGY (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection
Hideki Aizaki et al.
JOURNAL OF VIROLOGY (2008)
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein
Joerg Petersen et al.
NATURE BIOTECHNOLOGY (2008)
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans
Andreas Schulze et al.
HEPATOLOGY (2007)
Management of hepatitis B in liver transplant recipients
Carla S. Coffin et al.
JOURNAL OF VIRAL HEPATITIS (2007)
Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1) by bosentan:: A mechanism for species differences in hepatotoxicity
Elaine M. Leslie et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin
Mohamed A. El-Farrash et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs
Sachiko Mita et al.
DRUG METABOLISM AND DISPOSITION (2006)
pH-independent entry and sequential endosomal sorting are major determinants of hepadnaviral infection in primary hepatocytes
Anneke Funk et al.
HEPATOLOGY (2006)
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse et al.
HEPATOLOGY (2006)
Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
M Nakagawa et al.
GASTROENTEROLOGY (2005)
Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase
K Watashi et al.
MOLECULAR CELL (2005)
Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein
P Gripon et al.
JOURNAL OF VIROLOGY (2005)
Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation
EH Palacios et al.
ONCOGENE (2004)
Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors
GJ Towers et al.
NATURE MEDICINE (2003)
Requirement for cyclophilin A for the replication of vesicular stomatitis virus New Jersey serotype
S Bose et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Activation and inhibition of cellular calcium and tyrosine kinase signaling pathways identify targets of the HBx protein involved in hepatitis B virus replication
MJ Bouchard et al.
JOURNAL OF VIROLOGY (2003)
Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids
K Deres et al.
SCIENCE (2003)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
Infection of a human hepatoma cell line by hepatitis B virus
P Gripon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cyclosporins:: Structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter
F Loor et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Phenylpropenamide derivatives AT-61 and AT-130 inhibit replication of wild-type and lamivudine-resistant strains of hepatitis B virus in vitro
WE Delaney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Viral determinants and host immune responses in the pathogenesis of HBV infection
M Rapicetta et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model
O Weber et al.
ANTIVIRAL RESEARCH (2002)
Share Paper
